Pityriasis Rosea and Immunosuppressive Drugs [Letter]. [PDF]
Drago F, Fidanzi C, Ciccarese G.
europepmc +1 more source
Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination. [PDF]
Drago F, Broccolo F, Ciccarese G.
europepmc +1 more source
Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination
Kanchana Leerunyakul +2 more
openalex +1 more source
Pityriasis rosea and pityriasis rosea-like eruption: The distinction is relevant for diagnostic and prognostic reasons. [PDF]
Ciccarese G, Serviddio G, Drago F.
europepmc +1 more source
Reply to "the significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations" by Ciccarese G. et al. [PDF]
Martora F +4 more
europepmc +1 more source
Atypical pityriasis rosea associated with mRNA COVID‐19 vaccine
Ecem Bostan, Adam Jarbou
openalex +1 more source
Comparative Efficacy of Different Pharmacological Treatments for Pityriasis Rosea: A Network Meta-Analysis. [PDF]
Ciccarese G +6 more
europepmc +1 more source
Pityriasis Rosea Following Covaxin (BBV152) Vaccination for COVID-19. [PDF]
Singh BSTP, Kar BR, Agrawal I.
europepmc +1 more source
Terbinafine induced pityriasis rosea-like eruption
Anisha George +3 more
openalex +2 more sources

